(VIANEWS) – SPBK 1 ØSTLANDET (SPOL.OL), TOMRA SYSTEMS (TOM.OL), J.MARTINS,SGPS (JMT.LS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SPBK 1 ØSTLANDET (SPOL.OL)
25% sales growth and 10.98% return on equity
SpareBank 1 Østlandet provides various financial products and services to individuals, businesses, the public sector, clubs, and societies. The company operates through Retail, Corporate, and Organisation Market and Capital Market segments. The Retail segment provides financial services comprising of savings, money transfer, insurance, accident prevention, financing, money transfer, capital, and investment management services. The Corporate segment offers interest rate, currency hedging, and investment related services, as well as insurance services for property. The Organisation Market and Capital Market segment provides risk based advisory solutions to high-net-worth individuals and corporates, as well as engages in foreign currency services. SpareBank 1 Østlandet was founded in 1845 and is headquartered in Hamar, Norway. The company operates as a subsidiary of Sparebankstiftelsen Hedmark.
Earnings Per Share
As for profitability, SPBK 1 ØSTLANDET has a trailing twelve months EPS of kr11.9.
PE Ratio
SPBK 1 ØSTLANDET has a trailing twelve months price to earnings ratio of 10.47. Meaning, the purchaser of the share is investing kr10.47 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.98%.
More news about SPBK 1 ØSTLANDET.
2. TOMRA SYSTEMS (TOM.OL)
14% sales growth and 16.76% return on equity
Tomra Systems ASA provides sensor-based solutions for optimal resource productivity worldwide. It operates through three segments: TOMRA Collection, TOMRA Recycling, and TOMRA Food. The TOMRA Collection segment engages in the development, production, sale, and service of reverse vending machines and related data management systems. This segment is also involved in picking up, transporting, and processing empty beverage containers on behalf of beverage producers/fillers. The TOMRA Recycling segment engages in the development, production, sale, and service of sorting and processing technology for waste management companies or plant builders. This segment offers sorting systems for waste and metal material streams; and ore sorting systems for mining companies. The TOMRA Food segment is involved in the development, production, sale, and service of sorting and processing technology, including sensor-based sorting solutions and integrated post-harvest solutions to detect and eject unwanted materials from manufacturing and processing lines for fresh and processed food industries. The company was founded in 1972 and is headquartered in Asker, Norway.
Earnings Per Share
As for profitability, TOMRA SYSTEMS has a trailing twelve months EPS of kr3.48.
PE Ratio
TOMRA SYSTEMS has a trailing twelve months price to earnings ratio of 50.55. Meaning, the purchaser of the share is investing kr50.55 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.76%.
Moving Average
TOMRA SYSTEMS’s value is above its 50-day moving average of kr170.93 and under its 200-day moving average of kr188.02.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 1.8 and the estimated forward annual dividend yield is 1.03%.
Volume
Today’s last reported volume for TOMRA SYSTEMS is 54364 which is 85.51% below its average volume of 375340.
Sales Growth
TOMRA SYSTEMS’s sales growth is 17.6% for the present quarter and 14% for the next.
More news about TOMRA SYSTEMS.
3. J.MARTINS,SGPS (JMT.LS)
11.6% sales growth and 24.85% return on equity
Jerónimo Martins, SGPS, S.A. operates in the food distribution and specialized retail sectors in Portugal, Poland, and Colombia. The company operates through Portugal Retail; Portugal Cash & Carry; Poland Retail; Colombia Retail; and Others, Eliminations and Adjustments segments. It operates food stores under the Biedronka name; and a chain of health and beauty stores under the Hebe banner in Poland, as well as food stores under the Ara name in Colombia. The company also operates supermarkets under the Pingo Doce banner; and cash and carry stores under the Recheio name in Portugal. In addition, it operates restaurants under the Pingo Doce name; Bem-Estar pharmacies; petrol stations; and clothing under Code brand. Further, the company operates kiosks and coffee shops under the Jeronymo name; and chocolates and confectionary retail stores under Hussel name. Additionally, the company engages in human resources top management, real estate management and administration, training, and saline brackish waters aquaculture; wholesale of fruit and vegetables; retail management, consultancy, and logistics activities; the purchase and sale of real estate; growing of crops and farming of animals; retail sale of health and beauty products; manufacture of milk and dairy products; and provision of economic and accounting, business portfolio management, financial, and sea passenger water transport services. It is also involved in the trading and distribution of consumer goods; retail and wholesale of non-food products; other business support service activities; and provision of services in the area of wholesale and retail distribution. The company was founded in 1792 and is headquartered in Lisbon, Portugal. Jerónimo Martins, SGPS, S.A. is a subsidiary of Sociedade Francisco Manuel dos Santos, SGPS, S.E.
Earnings Per Share
As for profitability, J.MARTINS,SGPS has a trailing twelve months EPS of €1.02.
PE Ratio
J.MARTINS,SGPS has a trailing twelve months price to earnings ratio of 22.78. Meaning, the purchaser of the share is investing €22.78 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.85%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 26.68B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 15, 2023, the estimated forward annual dividend rate is 0.55 and the estimated forward annual dividend yield is 2.44%.
More news about J.MARTINS,SGPS.
4. ASML HOLDING (ASML.AS)
10.4% sales growth and 74.04% return on equity
ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems consisting of lithography, metrology, and inspection systems for memory and logic chipmakers. The company provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. It also offers metrology and inspection systems, including YieldStar optical metrology solutions to assess the quality of patterns on the wafers; and HMI e-beam solutions to locate and analyze individual chip defects. In addition, the company provides computational lithography and lithography process and control software solutions; and refurbishes and upgrades older lithography systems, as well as offers customer support and associated services. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
Earnings Per Share
As for profitability, ASML HOLDING has a trailing twelve months EPS of €17.62.
PE Ratio
ASML HOLDING has a trailing twelve months price to earnings ratio of 38.68. Meaning, the purchaser of the share is investing €38.68 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 74.04%.
Sales Growth
ASML HOLDING’s sales growth is 22.9% for the current quarter and 10.4% for the next.
Volume
Today’s last reported volume for ASML HOLDING is 86949 which is 86.75% below its average volume of 656379.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 9.5 and the estimated forward annual dividend yield is 1.46%.
Moving Average
ASML HOLDING’s value is way higher than its 50-day moving average of €600.19 and way above its 200-day moving average of €551.51.
More news about ASML HOLDING.
5. NAVAMEDIC (NAVA.OL)
9.6% sales growth and 22.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.74.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 21.26. Meaning, the purchaser of the share is investing kr21.26 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Volume
Today’s last reported volume for NAVAMEDIC is 4520 which is 83.04% below its average volume of 26666.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr37.00 at 12:20 EST, way under its 52-week high of kr43.60 and way above its 52-week low of kr25.00.
Moving Average
NAVAMEDIC’s worth is under its 50-day moving average of kr38.93 and above its 200-day moving average of kr35.04.
Revenue Growth
Year-on-year quarterly revenue growth grew by 93.3%, now sitting on 440.93M for the twelve trailing months.
More news about NAVAMEDIC.
